Note: Ingredients listed on restricted chemical lists
EC/CAS
207-838-8/497-19-8
Name of the chemical
Sodium carbonate
Concentration
50 - 70
General Information
Version
1.2
Revision date
2026-02-09
Product name
pH Buffer capsule pH 10,01 at 25°C
CAS No.
497-19-8
1.2.1 Relevant identified uses
Laboratory use
Emergency telephone
+34 937 077 970, 0344 892 0111
Icons in SDS
Company Information
company name
Labbox Labware S.L
e-mail address of the competent person responsible for the Safety Data Sheet
info@labbox.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H312, H319
Hazard statements
Code
Statements
H312
Harmful in contact with skin
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
No additional information available
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H312 - Harmful in contact with skin. H319 - Causes serious eye irritation.
Precautionary statements
P264 - Wash hands, forearms and face thoroughly after handling. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P302+P352 - IF ON SKIN: Wash with plenty of water. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312 - Call a POISON CENTRE or doctor if you feel unwell. P321 - Specific treatment (see supplemental first aid instruction on this label).
Other hazards which do not result in classification
Does not contain PBT and/or vPvB substances ≥ 0.1% evaluated according to Annex XIII of REACH. Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Acute toxicity (dermal), Category 4 H312 Serious eye damage/eye irritation, Category 2 H319 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects No additional information available